Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Synthetic Biology Market, by Application
1.4.2 North America Synthetic Biology Market, by End-use
1.4.3 North America Synthetic Biology Market, by Product
1.4.4 North America Synthetic Biology Market, by Technology
1.4.5 North America Synthetic Biology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Synthetic Biology Market by Application
4.1 North America Healthcare Market by Region
4.2 North America Non-healthcare Market by Region
Chapter 5. North America Synthetic Biology Market by End-use
5.1 North America Biotechnology and Pharmaceutical Companies Market by Country
5.2 North America Academic and Government Research Institutes Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Synthetic Biology Market by Product
6.1 North America Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country
6.2 North America Enzymes Market by Country
6.3 North America Cloning Technologies Kits Market by Country
6.4 North America Xeno-Nucleic Acids Market by Country
6.5 North America Chassis Organism Market by Country
Chapter 7. North America Synthetic Biology Market by Technology
7.1 North America PCR Technology Market by Country
7.2 North America NGS Technology Market by Country
7.3 North America Genome Editing Technology Market by Country
7.4 North America Bioprocessing Technology Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Synthetic Biology Market by Country
8.1 US Synthetic Biology Market
8.1.1 US Synthetic Biology Market by Application
8.1.2 US Synthetic Biology Market by End-use
8.1.3 US Synthetic Biology Market by Product
8.1.4 US Synthetic Biology Market by Technology
8.2 Canada Synthetic Biology Market
8.2.1 Canada Synthetic Biology Market by Application
8.2.2 Canada Synthetic Biology Market by End-use
8.2.3 Canada Synthetic Biology Market by Product
8.2.4 Canada Synthetic Biology Market by Technology
8.3 Mexico Synthetic Biology Market
8.3.1 Mexico Synthetic Biology Market by Application
8.3.2 Mexico Synthetic Biology Market by End-use
8.3.3 Mexico Synthetic Biology Market by Product
8.3.4 Mexico Synthetic Biology Market by Technology
8.4 Rest of North America Synthetic Biology Market
8.4.1 Rest of North America Synthetic Biology Market by Application
8.4.2 Rest of North America Synthetic Biology Market by End-use
8.4.3 Rest of North America Synthetic Biology Market by Product
8.4.4 Rest of North America Synthetic Biology Market by Technology
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Genscript Biotech Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 DNA TwoPointO Inc. (Atum)
9.3.1 Company Overview
9.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Eurofins Scientific SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 SWOT Analysis
9.6 OriGene Technologies, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Twist Bioscience Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Editas Medicine, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.8.4 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Merck KGaA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 